Schizophrenia-Psychotic Disorders & Antipsychotics

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

 

3 - Clinical response to risperidone in relation to plasma drug concentrations in acutely exacerbated schizophrenic patients

N Yasui-Furukori, M Saito, T Nakagami, H Furukori, A Suzuki, T Kondo, and S Kaneko

Journal of Psychopharmacology 2009 First published on May 28, 2009

3 - Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years

M X Patel, P M Haddad, I B Chaudhry, S McLoughlin, N Husain, and A S David

Journal of Psychopharmacology First published on May 28, 2009

5< - Zolmitriptan compared to propranolol in the treatment of acute neuroleptic-induced akathisia: A comparative double-blind study

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Ayelet Avital, Ruth Gross-Isseroff, Rafael Stryjer, Haggai Hermesh, Abraham Weizman and Roni Shiloh

European Neuropsychopharmacology. Volume 19, Issue 7, July 2009, Pages 476-482

 

3! - Increased use of antibiotics in patients treated with clozapine

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Jimmi Nielsen, Leslie Foldager and Jonathan M. Meyer

European Neuropsychopharmacology. Volume 19, Issue 7, July 2009, Pages 483-486

 

3! - Changes in prefrontal and amygdala activity during olanzapine treatment in schizophrenia

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Giuseppe Blasi, Teresa Popolizio, Paolo Taurisano, Grazia Caforio, Raffaella Romano, Annabella Di Giorgio, Fabio Sambataro, Valeria Rubino, Valeria Latorre, Luciana Lo Bianco, Leonardo Fazio, Marcello Nardini, Daniel R. Weinberger and Alessandro Bertolino

Psychiatry Research: Neuroimaging. Volume 173, Issue 1, 15 July 2009, Pages 31-38

 

3 - Efficacy and Tolerability of Aripiprazole in First-Episode Drug-Naive Patients With Schizophrenia: An Open-Label Trial

Takahashi, Hitoshi; Oshimo, Takashi; Ishigooka, Jun

Clinical Neuropharmacology: May/June 2009 - Volume 32 - Issue 3 - pp 149-150

 

3! - Moclobemide Treatment of Clozapine-Induced Hypersalivation: Pilot Open Study

Kreinin, Anatoly; Miodownik, Chanoch; Libov, Igor; Shestakova, Diana; Lerner, Vladimir

Clinical Neuropharmacology: May/June 2009 - Volume 32 - Issue 3 - pp 151-153

 

3 - N-Desmethylclozapine: Is There Evidence for its Antipsychotic Potential?

Mendoza, Maria Cristina; Lindenmayer, J.P

Clinical Neuropharmacology: May/June 2009 - Volume 32 - Issue 3 - pp 154-157

 

3! - Impact of psychotic relapse definitions in assessing drug efficacy and costs: comparison of quetiapine XR, olanzapine and paliperidone ER

Martin Knapp‌, Julie Locklear‌ and Krister Järbrink‌

Current Medical Research and Opinion. Posted online on 26 May 2009.

 

3 - Sexual dysfunction and hormonal changes in first episode psychosis patients on olanzapine or risperidone

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Marion van Bruggen, Thérèse van Amelsvoort, Luuk Wouters, Peter Dingemans, Lieuwe de Haan and Don Linszen

Psychoneuroendocrinology. Volume 34, Issue 7, August 2009, Pages 989-995

 

4 - Cognitive Effects of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: A Randomized, Open-Label Clinical Trial (EUFEST)

Michael Davidson, Silvana Galderisi, Mark Weiser, Nomi Werbeloff, Wolfgang W. Fleischhacker, Richard S. Keefe, Han Boter, Ireneus P.M. Keet, Dan Prelipceanu, Janusz K. Rybakowski, Jan Libiger, Martina Hummer, Sonia Dollfus, Juan J. López-Ibor, Luchezar G. Hranov, Wolfgang Gaebel, Joseph Peuskens, Nils Lindefors, Anita Riecher-Rössler, and René S. Kahn

Am J Psychiatry 2009; 166:675-682

5 - Randomized, Double-Blind, Placebo-Controlled Study of Paliperidone Extended-Release and Quetiapine in Inpatients With Recently Exacerbated Schizophrenia

Carla M. Canuso, Bryan Dirks, Jennifer Carothers, Colette Kosik-Gonzalez, Cynthia A. Bossie, Young Zhu, C. V. Damaraju, Amir H. Kalali, and Ramy Mahmoud

Am J Psychiatry 2009; 166:691-701

3! - Incidence and persistence of tardive dyskinesia and extrapyramidal symptoms in schizophrenia

DE Tenback, PN van Harten, CJ Slooff, and J van Os

Journal of Psychopharmacology First published on June 1, 2009

3! - Medication Nonadherence and Treatment Outcome in Patients With Schizophrenia or
Schizoaffective Disorder With Suboptimal Prior Response

Jean-Pierre Lindenmayer, Hong Liu-Seifert, Pandurang M. Kulkarni, Bruce J. Kinon, Virginia Stauffer, Sara E. Edwards, Lei Chen, David H. Adams, Haya Ascher-Svanum, Peter F. Buckley, Leslie Citrome, and Jan Volavka

J Clin Psychiatry June 2, 2009: e1-e7

 

3 - Neuroleptic Malignant Syndrome Associated with Atypical Antipsychotic Drugs

Trollor, Julian N; Chen, Xiaohua; Sachdev, Perminder S

CNS Drugs. 23(6):477-492, May 30, 2009

3 - Efficacy and Tolerability of Aripiprazole in First-Episode Drug-Naive Patients With Schizophrenia: An Open-Label Trial

Takahashi, Hitoshi; Oshimo, Takashi; Ishigooka, Jun

Clinical Neuropharmacology: May/June 2009 - Volume 32 - Issue 3 - pp 149-150

 

3! - Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors

Rita C. Carvalho, Daniela F. Fukushiro, Daniel C. Helfer, Donato Callegaro-Filho, Thaís F. Trombin, Lineane H. F. Zanlorenci, Leandro Sanday, Regina H. Silva & Roberto Frussa-Filho

Addiction Biology. Volume 14 Issue 3, Pages 283 - 293

 

3! - A Critique of the Dopamine Hypothesis of Schizophrenia and Psychosis

Joanna Moncrieff

Harvard Review of Psychiatry, Volume 17, Issue 3 June 2009, pages 214 - 225

 

3! - Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortex

S Yamamura, K Ohoyama, T Hamaguchi, M Nakagawa, D Suzuki, T Matsumoto, E Motomura, H Tanii, T Shiroyama and M Okada

British Journal of Pharmacology (2009) 157, 656–665

 

3! - A systematic review of cardiovascular effects after atypical antipsychotic medication overdose

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Hock Heng Tan, Jason Hoppe and Kennon Heard

The American Journal of Emergency Medicine. Volume 27, Issue 5, June 2009, Pages 607-616

 

5 - Proof-of-Concept Trial with the Neurosteroid Pregnenolone Targeting Cognitive and Negative Symptoms in Schizophrenia

Christine E Marx, Richard S E Keefe, Robert W Buchanan, Robert M Hamer, Jason D Kilts, Daniel W Bradford, Jennifer L Strauss, Jennifer C Naylor, Victoria M Payne, Jeffrey A Lieberman, Adam J Savitz, Linda A Leimone, Lawrence Dunn, Patrizia Porcu, A Leslie Morrow and Lawrence J Shampine

Neuropsychopharmacology (2009) 34, 1885–1903

 

2 - Restless legs syndrome and periodic limb movements during sleep probably associated with olanzapine

Seung-Gul Kang, Heon-Jeong Lee, Leen Kim

Journal of Psychopharmacology, Vol. 23, No. 5, 597-601 (2009)

3 - From Real-World Events to Psychosis: The Emerging Neuropharmacology of Delusions

Paul D. Morrison and R. M. Murray

Schizophrenia Bulletin 2009 35(4):668-674

 

5 - Dropout Rates in Randomized Clinical Trials of Antipsychotics: A Meta-analysis Comparing First- and Second-Generation Drugs and an Examination of the Role of Trial Design Features

Jonathan Rabinowitz, Stephen Z. Levine, Orna Barkai and Ori Davidov

Schizophrenia Bulletin 2009 35(4):775-788

 

3! - Cortical Dopamine D₂/D₃ Receptors Are a Common Site of Action for Antipsychotic Drugs—An Original Patient Data Meta-analysis of the SPECT and PET In Vivo Receptor Imaging Literature

James M. Stone, John M. Davis, Stefan Leucht and Lyn S. Pilowsky

Schizophrenia Bulletin 2009 35(4):789-797

 

3 - Modeling and Simulation of the Time Course of Asenapine Exposure Response and Dropout Patterns in Acute Schizophrenia

LE Friberg, R de Greef, T Kerbusch and MO Karlsson

Clinical Pharmacology & Therapeutics (2009); 86, 1, 84–91

 

3! - Quetiapine overdose: predicting intubation, duration of ventilation, cardiac monitoring and the effect of activated charcoal

Isbister, Geoffrey K; Duffull, Stephen B

International Clinical Psychopharmacology: July 2009 - Volume 24 - Issue 4 - pp 174-180

 

3 - A 12-week, naturalistic switch study of the efficacy and tolerability of aripiprazole in stable outpatients with schizophrenia or schizoaffective disorder

Lee, Min-Soo; Jun, Tae-Youn; Jung, Hee-Yeon; Kim, Chang Yoon; Chung, Seockhoon; Lee, Joon-Noh; Kwon, Jun Soo; Kim, Do Hoon; Kim, Chul Eung; Jeong, Bumseok; Jeon, Yang-Whan

International Clinical Psychopharmacology:  July 2009 - Volume 24 - Issue 4 - pp 181-188

 

3! - Risk of lipid abnormality with haloperidol, olanzapine, quetiapine, and risperidone in a Veterans Affairs population

Duncan, Erica J; Woolson, Sandra L; Hamer, Robert M; Dunlop, Boadie W

International Clinical Psychopharmacology: July 2009 - Volume 24 - Issue 4 - pp 204-213

 

3 - Prescription of antipsychotic medication to patients at ultra high risk of developing psychosis

Nieman, Dorien H; Rike, Wera H; Becker, Hiske E; Dingemans, Peter M; van Amelsvoort, Thérèse A; de Haan, Lieuwe; van der Gaag, Mark; Denys, Damiaan A.J.P; Linszen, Don H

International Clinical Psychopharmacology: July 2009 - Volume 24 - Issue 4 - pp 223-228

 

3 - The role of cannabis in cognitive functioning of patients with schizophrenia

Original Investigation

The role of cannabis in cognitive functioning of patients with schizophrenia

Thomas Schnell, Dagmar Koethe, Jörg Daumann and Euphrosyne Gouzoulis-Mayfrank

Psychopharmacology. Volume 205, Number 1 / julio de 2009: 45-52

 

3! - Amisulpride is a potent 5-HT₇ antagonist: relevance for antidepressant actions in vivo

Original Investigation

Amisulpride is a potent 5-HT₇ antagonist: relevance for antidepressant actions in vivo

Atheir I. Abbas, Peter B. Hedlund, Xi-Ping Huang, Thuy B. Tran, Herbert Y. Meltzer and Bryan L. Roth

Psychopharmacology. Volume 205, Number 1 / julio de 2009: 119-128

 

3 - Unique Antipsychotic Activities of the Selective Metabotropic Glutamate Receptor 1 Allosteric Antagonist 2-Cyclopropyl-5-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-2,3-dihydro-1H-isoindol-1-one

Akio Satow, Gentaroh Suzuki, Shunsuke Maehara, Hirohiko Hikichi, Takeshi Murai, Takashi Murai, Hiroko Kawagoe-Takaki, Mikiko Hata, Satoru Ito, Satoshi Ozaki, Hiroshi Kawamoto, and Hisashi Ohta

JPET 330:179-190, 2009

 

3 - The cost of relapse in patients with schizophrenia in the European SOHO (Schizophrenia Outpatient Health Outcomes) study

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Jihyung Hong, Frank Windmeijer, Diego Novick, Josep Maria Haro and Jacqueline Brown

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 5, 1 August 2009, Pages 835-841

3! - Bipolar Disorder, Schizoaffective Disorder, and Schizophrenia Overlap: A New Comorbidity Index

Thomas Munk Laursen, Esben Agerbo, and Carsten Bøcker Pedersen

J Clin Psychiatry June 16, 2009: e1-e7

 

3 - Applicability of a Genetic Signature for Enhanced Iloperidone Efficacy in the Treatment of Schizophrenia

Simona Volpi, Steven G. Potkin, Anil K. Malhotra, Louis Licamele, and Christian Lavedan

J Clin Psychiatry 2009;70(6):801-809

 

5 - Lurasidone in the Treatment of Acute Schizophrenia: A Double-Blind, Placebo-Controlled Trial

Mitsutaka Nakamura, Masaaki Ogasa, John Guarino, Debra Phillips, Joseph Severs, Josephine Cucchiaro, and Antony Loebel

J Clin Psychiatry 2009;70(6):829-836

 

5 - The Efficacy and Safety of Blonanserin Compared with Haloperidol in Acute-Phase Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Multicentre Study

Garcia, Esther; Robert, Marta; Peris, Francesc; Nakamura, Hiroshi; Sato, Noriko; Terazawa, Yoshikatsu

CNS Drugs. 23(7):615-625, July 7, 2009

3 - Effect of alpha lipoic acid on the tardive dyskinesia and oxidative stress induced by haloperidol in rats

Basic Neurosciences, Genetics and Immunology - Original Article

Effect of alpha lipoic acid on the tardive dyskinesia and oxidative stress induced by haloperidol in rats

Santhrani Thaakur and G. Himabindhu

Journal of Neural Transmission. Volume 116, Number 7 / julio de 2009: 807-814

 

3 - Melperone, an aytpical antipsychotic drug with clozapine-like effect on plasma prolactin: contrast with typical neuroleptics

William V. Bobo, Karuna Jayathilake, Myung A. Lee, Herbert Y. Meltzer

Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue 5, Pages 415 - 422

 

GRATIS 3! - Effectiveness of clozapine, haloperidol and chlorpromazine in schizophrenia during a five-year period

RAVANIC, Dragan B et al.

Arq. Neuro-Psiquiatr 2009, vol.67, n.2a, pp. 195-202

 

GRATIS 3 (previo registro) - The Psychosis Continuum and 
Categorical Versus Dimensional 
Diagnostic Approaches


Michelle L. Esterberg, and Michael T. Compton 

Current Psychiatry Reports 2009, 11: (3) 179-184

 

GRATIS 3 (previo registro) - Cotard’s Syndrome: A Review

Hans Debruyne, Michael Portzky, Frédérique Van den Eynde, and Kurt Audenaert
Current Psychiatry Reports 2009, 11: (3) 197-202

 

3 - In search of moderators and mediators of hyperglycemia with atypical antipsychotic treatment

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Gerald M. Reaven, Jeffrey A. Lieberman, Gopalan Sethuraman, Helena Kraemer, John M. Davis, Christine Blasey, Ming T. Tsuang and Alan F. Schatzberg

Journal of Psychiatric Research. Volume 43, Issue 11, July 2009, Pages 997-1002

 

3! - Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Diego Novick, Josep Maria Haro, Elena Perrin, David Suarez and João Marques Texeira

European Neuropsychopharmacology. Volume 19, Issue 8, August 2009, Pages 542-550

 

3 - Immediate versus gradual suspension of previous treatments during switch to aripiprazole: Results of a randomized, open label study

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Chi-Un Pae, Alessandro Serretti, Alberto Chiesa, Laura Mandelli, Changuk Lee, Chul Lee, Jungjin Kim, Diana De Ronchi and In-Ho Paik

European Neuropsychopharmacology. Volume 19, Issue 8, August 2009, Pages 562-570

.

Regresar a RESÚMENES JUNIO 2009